## Abstract Antihistamines are structurally similar to DPPE, a tamoxifen derivative known to promote tumor growth, and to antidepressants. Animal experiments have linked certain antihistamines and antidepressants with enhanced tumor growth in mice. The few epidemiologic studies examining antihistam
Statin use and risk of breast cancer
β Scribed by Gaia Pocobelli; Polly A. Newcomb; Amy Trentham-Dietz; Linda Titus-Ernstoff; John M. Hampton; Kathleen M. Egan
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 89 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND.
Findings that statins inhibited the proliferation of breast cancer cells in vitro and in rodents have raised interest in whether the use of statins might decrease a woman's risk of developing breast cancer. We analyzed data from a populationβbased caseβcontrol study to evaluate the association between the use of statins and breast cancer risk.
METHODS.
Cases of incident invasive breast cancer in women 50 years of age or older and diagnosed from 1995β2001 were identified from populationβbased cancer registries in Wisconsin, Massachusetts, and New Hampshire. Controls were randomly selected, within each state, from lists of licensed drivers and Medicare beneficiaries. Information on the use of statins and other breast cancer risk factors was ascertained from structured telephone interviews.
RESULTS.
Overall, breast cancer cases were not more likely than controls to have ever used statins. Ever use of lipophilic statins as a group (simvastatin, lovastatin, and fluvastatin) and ever use of the hydrophilic statin pravastatin were also not associated with breast cancer risk. Ever use of fluvastatin was associated with a decreased risk of breast cancer (odds ratio [OR], 0.5; 95% confidence interval, 0.3β0.8) but the magnitude of the ORs did not vary across categories of duration of use.
CONCLUSIONS.
The use of statins overall was not associated with breast cancer risk. Cancer 2008. Β© 2007 American Cancer Society.
π SIMILAR VOLUMES
Purpose - The study was conducted to examine whether use of cimetidine is associated with the risk of cancer, with special attention to cancers of the breast and prostate because cimetidine increases estradiol levels and interferes with androgen binding. Methods - Individuals who received a prescrip
## Abstract We conducted a systematic review of the association between HMGβCoA reductase inhibitor (statin) use and cancer risk. We searched MEDLINE, EMBASE, Web of Science, ISI Proceedings and BIOSIS Previews bibliographic databases, electronic trials registers and reference lists for potentially
We examined the association between oral contraceptive use and risk of specific breast cancer histopathologies in a large, multi-center, population-based, case-control study. Women younger than age 75 with a new diagnosis of invasive breast cancer were identified from 4 statewide tumor registries. W